Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia

Gynecologic Oncology

Volumn 103, Issue 1, 2006, Pages 307-314

  Villavicencio, A ^a   Bacallao, K ^a   Avellaira, C ^a   Gabler, F ^b   Fuentes, A ^a   Vega, M ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Co regulators; Endometrium; Polycystic ovary syndrome; Steroid receptors

Indexed keywords

ANDROGEN RECEPTOR; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; NUCLEAR RECEPTOR COREPRESSOR; PROTEIN; PROTEIN ARA70; STEROID RECEPTOR COACTIVATOR 3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENDOMETRIUM; ENDOMETRIUM HYPERPLASIA; FEMALE; GENE EXPRESSION; HORMONE SENSITIVITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ADULT; ENDOMETRIAL HYPERPLASIA; ENDOMETRIUM; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION; HISTONE ACETYLTRANSFERASES; HUMANS; NUCLEAR PROTEINS; ONCOGENE PROTEINS; POLYCYSTIC OVARY SYNDROME; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; REPRESSOR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 33748684457     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.03.029     Document Type: Article

References (49)

1. Chang R.J. Polycystic ovary syndrome: diagnostic criteria. In: Chang R.J., Heindel J.J., and Dunaif A. (Eds). Polycystic ovary syndrome (2002), Marcel Dekker, New York 361-365
2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 (2004) 41-47
3. Adams J., Polson D.W., and Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J [Clin Res Ed] 293 (1986) 355-359
4. Sagle M., Bishop K., Ridley N., Alexander F.M., Michel M., Bonney R.C., et al. Recurrent early miscarriage and polycystic ovaries. BMJ 297 (1998) 1024-1026
5. Tulppala M., Stenman U.H., Cacciatore B., and Ylikorkala O. Polycystic ovaries and levels of gonadotrophins and androgen in recurrent miscarriage: prospective study in 50 women. Br J Obstet Gynaecol 100 (1993) 348-352
6. Balen A. Polycystic ovary syndrome and cancer. Hum Reprod Update 7 (2001) 522-525
7. Hardiman P., Pillay O.C., and Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 361 (2003) 1810-1812
8. Chamlian D.L., and Taylor H.B. Endometrial hyperplasia in young women. Obstet Gynecol 36 (1970) 659-666
9. Cheung A.P. Ultrasound and menstrual history in predicting endometrial hyperplasia in polycystic ovary syndrome. Obstet Gynecol 98 (2001) 325-331
10. Dunaif A., Segal K.R., Futterweit W., and Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38 (1989) 1165-1174
11. Randolph J.F., Kipersztok S., and Ayers J.W. The effect of insulin on aromatase activity in isolated human endometrial glands and stroma. Am J Obstet Gynecol 157 (1987) 1534-1539
12. Nagamani M., and Stuart C.A. Specific binding and growth-promoting activity of insulin in endometrial cancer cells in culture. Am J Obstet Gynecol 179 (1998) 6-12
13. Ehrmann D.A., Barnes R.B., Rosenfield R.L., Cavaghan M.K., and Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22 (1999) 141-146
14. ACOG practice bulletin. Polycystic ovary syndrome. Obstet Gynecol 100 (2002) 1389-1402
15. Ehrmann D.A. Polycystic ovary syndrome. N Engl J Med 352 (2005) 1223-1236
16. McKenna N.J., Lanz R.B., and O'Malley B.W. Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20 (1999) 321-344
17. Gregory C.W., Wilson E.M., Apparao K.B.C., Lininger R.A., Meyer W.R., Kowalik A., et al. Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium. J Clin Endocrinol Metab 87 (2002) 2960-2966
18. Wieser F., Schneeberger C., Hudelist G., Singer C., Kurz C., Nagele F., et al. Endometrial nuclear receptor co-factors SRC-1 and N-CoR are increased in human endometrium during menstruation. Mol Hum Reprod 8 (2002) 644-650
19. Shiozawa T., Shih H.C., Miyamoto T., Feng Y.Z., Uchikawa J., Itoh K., et al. Cyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium. J Clin Endocrinol Metab 88 (2003) 871-878
20. Kershah S.M., Desouki M.M., Koterba K.L., and Rowan B.G. Expression of estrogen receptor coregulators in normal and malignant human endometrium. Gynecol Oncol 92 (2004) 304-313
21. Yeh S., Sampson E.R., Lee D.K., Kim E., Hsu C.-L., Chen Y.-L., et al. Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer. J Formos Med Assoc 99 (2000) 885-894
22. Yeh S., and Chang C. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci U S A 93 (1996) 5517-5521
23. Alen P., Claessens F., Schoenmakers E., Swinnen J.V., Verhoeven G., Rombauts W., et al. Interaction of the putative androgen receptor-specific coativator ARA70/ELEI alpha with multiple steroid receptors and identification of an internally deleted ELEI beta isoforma. Mol Endocrinol 13 (1999) 117-128
24. Gao X., Loggie B.W., and Nawaz Z. The roles of sex steroid receptor coregulators in cancer. Mol Cancer 1 (2002) 1-7
25. Zhang X., Jeyakumar M., Petukhov S., and Bagchi M.K. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor. Mol Endocrinol 12 (1998) 513-524
26. Huang H.J., Norris J.D., and McDonnell D.P. Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists. Mol Endocrinol 16 (2002) 1778-1792
27. Torchia J., Glass C., and Rosenfeld M.G. Co-activators and co-repressors in the integration of transcriptional responses. Curr Opin Cell Biol 10 (1998) 373-383
28. Noyes R.W., Hertig D.T., and Rock J. Dating the endometrial biopsy. Fertil Steril 1 (1950) 3-25
29. Brandenberger A.W., Tee M.K., Lee J.Y., Chao V., and Jaffe R.B. Tissue distribution of estrogen receptors alpha (ER-α) and (ER-β) mRNA in the midgestational human fetus. J Clin Endocrinol Metab 82 (1997) 3509-3512
30. Apparao K.B.C., Lovely L.P., Gui Y., Lininger R.A., and Lessey B.A. Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol Reprod 66 (2002) 297-304
31. Lessey B.A., Killam A.P., Metzger D.A., Haney A.F., Greene G.L., and McCarty K.S. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab 67 (1988) 334-340
32. Castro A., Johnson M.C., Anido M., Cortinez A., Gabler F., and Vega M. Role of nitric oxide and bcl-2 family genes in the regulation of human endometrial apoptosis. Fertil Steril 78 (2002) 587-595
33. Iñiguez G., Villavicencio A., Gabler F., Palomino A., and Vega M. Effect of nitric oxide on the expression of insulin-like growth factors and insulin-like growth factor binding proteins throughout the lifespan of the human corpus luteum. Reproduction 122 (2001) 865-873
34. Shang Y., Hu X., DiRenzo J., Lazar M.A., and Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103 (2000) 843-852
35. Fujimoto J., Nishigaki M., Hori M., Ichigo S., Itoh T., and Tamaya T. The effect of estrogen and androgen on androgen receptors and mRNA levels in uterine leiomyoma, myometrium and endometrium of human subjects. J Steroid Biochem Mol Biol 50 (1994) 137-143
36. Lovely L.P., Apparao K.B.C., Gui Y., and Lessey B.A. Characterization of the androgen receptor in a well-differentiated endometrial adenocarcinoma cell line (Ishikawa). J Steroid Biochem Mol Biol 74 (2000) 235-241
37. Slayden O.D., Nayak N.R., Burton K.A., Chwalisz K., Cameron S.T., Critchley H.O., et al. Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium. J Clin Endocrinol Metab 86 (2001) 2668-2679
38. Weihua Z., Makela S., Andersson L.C., Salmi S., Saji S., Webster I., et al. A role for estrogen receptor β in the regulation of growth of the ventral prostate. PNAS 98 (2001) 6330-6335
39. Bjornstrom L., and Sjoberg M. Estrogen receptor-dependent activation of AP-1 via non-genomic signaling. Nucl Recept 2 (2004) 3
40. Heinlein C.A., and Chang C. Androgen receptor (AR) coregulators: an overview. Endocr Rev 23 (2002) 175-200
41. Klinge C.M. Estrogen receptor interaction with co-activators and co-repressors. Steroids 65 (2000) 227-251
42. Anzick S.L., Kononem J., Walker R.L., Azorsa D.O., Tanner M.M., Guan X.Y., et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277 (1997) 965-968
43. Wang Y., Wu M.C., Sham J.S., Zhang W., Wu W.Q., and Guan X.Y. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray. Cancer 95 (2002) 2346-2352
44. Sakakura C., Hagiwara A., Yasuoka R., Fujita Y., Nakanishi M., Masuda K., et al. Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int J Cancer 89 (2000) 217-223
45. Torres-Arzayus M.I., Font de Mora J., Yuan J., Vazquez F., Bronson R., Rue M., et al. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 6 (2004) 263-274
46. Leo C., and Don Chen J. The SRC family of nuclear receptor coactivators. Gene 245 (2000) 1-11
47. Kollara A., Kahn H.J., Marks A., and Brown T. Loss of androgen receptor associated protein 70 (ARA70) expression in a subset of HER2-positive breast cancers. Breast Cancer Res Treat 67 (2001) 245-253
48. Hermanson O., Glass C.K., and Rosenfel M. Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol Metab 13 (2002) 55-60
49. Boutell J.M., Thomas P., Neal J.W., Weston V.J., Duce J., Harper P.S., et al. Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin. Hum Mol Genet 8 (1999) 1647-1655